Traditions of the Kyrgyz people were being formed with the help of economic, trade, domestic and other relations with kindred and other tribes that were closely related to the geography of their ha...

After the coup of 19 March 1953 in the socio-political history of Iran there were fundamental changes: the powers of parliament were limited and the absolute power of Mohammad Reza Shah Pahlavi was...

In the Middle East, Saudi Arabia and the Islamic Republic of Iran are two countries that claim to leadership in the region. With a powerful resources and political potential these countries are the...

National Drug Formulary Created In Kazakhstan

Tuesday, December 29, 2015 - 10:28

The national drug formulary has been drawn-up in Kazakhstan, as reported by Larisa Pak, the Deputy Chairperson of the Committee on the Control of Pharmaceutical and Medical Activities under the Ministry of Health and Social Development, during a briefing at the Central Communications Office on December 28. She said, “Issues related to drug supply are issues of national security. That is why all countries should have their own national policies in the field of drug supply, which would address the issues of safety, quality and affordability of medicines provided to the population.”


According to Larisa Pak, Kazakhstan is to introduce the National Drug Formulary in order to ensure rational use of medicines. The formulary will include information on all registered medicines with proven clinical efficacy, as well as information on possible side effects and the price range for each medicinal product.


“The formulary will enable us to expand the competitive environment, while improving the transparency of the procurement process. It also will provide a choice of drugs based on the patient-centered model of drug supply. In general, the formulary will become a single large directory designed for both doctors and ordinary citizens of Kazakhstan. In addition, it will enable all health care organizations to form their own drug formularies for planning the budget with consideration of the price and profile of drugs,” Larisa Pak said.


To date, the formulary includes 616 international non-proprietary names of various drugs, while the State Register of Medicinal Products includes 2,842 drugs with their marginal prices specified.

URL of this article: